Unknown

Dataset Information

0

Harnessing Genomics to Predict and Prevent Anthracycline-Associated Cardiotoxicity.

ABSTRACT:

SUBMITTER: Sapkota Y 

PROVIDER: S-EPMC8352100 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.
| S-EPMC7048046 | biostudies-literature
Unknown Risk factors for anthracycline-associated cardiotoxicity.
| S-EPMC4874738 | biostudies-literature
Unknown Epigenetic Changes Associated With Anthracycline-Induced Cardiotoxicity.
| S-EPMC7877852 | biostudies-literature
Unknown High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity.
| S-EPMC7198830 | biostudies-literature
Unknown Coronary microcirculation damage in anthracycline cardiotoxicity.
| S-EPMC8803079 | biostudies-literature
Unknown Risk Factors for Anthracycline-Induced Cardiotoxicity.
| S-EPMC8511483 | biostudies-literature
Unknown P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
| S-EPMC4133592 | biostudies-literature
Unknown Anthracycline-induced cardiotoxicity: prospective cohort study from Pakistan.
| S-EPMC3840341 | biostudies-literature
Unknown Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
| S-EPMC5135038 | biostudies-literature
Unknown Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors.
| S-EPMC5575079 | biostudies-literature